Necrotizing Pneumonia

Pediatric Annals
|February 14, 2017
PubMed

Insights

Necrotizing pneumonia, an increasing community-acquired pneumonia, involves lung tissue death. While complications are common, children with this condition generally have a promising prognosis and survive.

Area of Science:

  • Pediatric infectious diseases
  • Pulmonary medicine
  • Critical care

Background:

  • Necrotizing pneumonia is a severe form of community-acquired pneumonia characterized by lung parenchymal necrosis, liquefaction, and cavitation.
  • Its incidence has been observed to be increasing over the past two decades.

Observation:

  • Common symptoms include fever, tachypnea, and cough.
  • Patients often develop complications like parapneumonic effusions, empyemas, or bronchopleural fistulae.
  • Necrotizing pneumonia is associated with elevated white blood cell counts and inflammatory markers, prolonged symptom duration, and extended hospital stays compared to non-necrotizing pneumonia.

Findings:

  • Despite frequent complications, the overall prognosis for necrotizing pneumonia is promising.
  • Nearly all affected children survive the illness.

Implications:

  • Early recognition and management of necrotizing pneumonia are crucial due to its increasing incidence and potential for severe complications.
  • Further research into optimizing treatment strategies may improve outcomes and reduce long-term sequelae.
  • Understanding the long-term prognosis and potential sequelae is important for pediatric patient care.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.7K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
7.0K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.8K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
979